Jean Jacques Bienaime, Director at Immunome Inc. (IMNM), bought 14,000 shares at $8.21 ($115K) on 2025-03-24, disclosed to the SEC on 2025-03-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.21 | 7,000 | $57K | 50.0% |
| 2 | $8.21 | 7,000 | $57K | 50.0% |
| Total | $8.21 avg | 14,000 | $115K | 100% |
| Filing → |
| KROS | BUY | 2026-07-17 | $11K | — | Filing → |
| KROS | BUY | 2026-06-17 | $10K | — | Filing → |
| IMNM | BUY | 2026-06-09 | $204K | — | Filing → |